Literature DB >> 2374185

Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma.

P Hermanek1, K M Schrott.   

Abstract

The predictive strengths of the third and new fourth editions of the tumor, nodes and metastasis classification are compared using 872 cases of operatively treated renal cell carcinoma. The new tumor, nodes and metastasis classification facilitates an improved assessment of prognosis by subdivision of the former category pT3 into pT3a and pT3b. The new pN classification permits recognition of an especially unfavorable subgroup (pN3) in patients with regional lymph node metastases. The new stage grouping makes a rough subdivision of patients into groups with different prognoses. However, stages 1 and 2 show similar survival rates. Compared to the commonly used Robson stages, the International Union Against Cancer stage grouping has advantages as well as disadvantages. Any resulting recommendations for modification of stages should be subject to testing by other institutions.

Entities:  

Mesh:

Year:  1990        PMID: 2374185     DOI: 10.1016/s0022-5347(17)39420-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification.

Authors:  M Takahashi; D R Rhodes; K A Furge; H Kanayama ; S Kagawa; B B Haab; B T Teh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

Review 2.  Imaging of advanced renal cell carcinoma.

Authors:  Ullrich G Mueller-Lisse; Ulrike L Mueller-Lisse
Journal:  World J Urol       Date:  2010-05-11       Impact factor: 4.226

Review 3.  Perspectives in drug development for metastatic renal cell cancer.

Authors:  Bristi Basu; Tim Eisen
Journal:  Target Oncol       Date:  2010-08-06       Impact factor: 4.493

4.  Laparoscopic partial nephrectomy for tumours >4 cm compared with smaller tumours: perioperative results.

Authors:  A Nouralizadeh; N Simforoosh; A Tabibi; A Basiri; S A M Ziaee; M Soleimani; M H Radfar; M Abedinzadeh; A H Kashi
Journal:  Int Urol Nephrol       Date:  2010-08-01       Impact factor: 2.370

5.  Prognostic value of the immunomonitoring of patients with renal cell carcinoma under therapy with IL-2/IFN-alpha-2 in combination with 5-FU.

Authors:  B Göhring; D Riemann; U Rebmann; H Heynemann; J Schabel; J Langner
Journal:  Urol Res       Date:  1996

6.  Surgical resection of a renal cell carcinoma involving the inferior vena cava: the role of the cardiothoracic surgeon.

Authors:  Haralabos Parissis; Mohammad Taukeer Akbar; Michael Tolan; Vincent Young
Journal:  J Cardiothorac Surg       Date:  2010-11-05       Impact factor: 1.637

7.  Adjuvant treatment of locally advanced renal cancer with autologous virus-modified tumor vaccines.

Authors:  H H Kirchner; P Anton; J Atzpodien
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

8.  [Renal cell carcinoma. Comparative analysis of the prognostic significance of the WHO-classification and the Störkel's prognostic score].

Authors:  S Gunia; M May; K Korb; P Stosiek
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

Review 9.  Long-term outcomes of the surgical management of renal cell carcinoma.

Authors:  John S Lam; Arie S Belldegrun; Allan J Pantuck
Journal:  World J Urol       Date:  2006-02-15       Impact factor: 4.226

10.  Staging of renal cell carcinoma: Current concepts.

Authors:  John S Lam; Tobias Klatte; Alberto Breda
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.